Page 22 - Biosecurity Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian variant strain of SARS-CoV-2 detected in Melbourne What does this mean and what should I do? COVID-19 restrictions are being reimposed in Melbourne as authorities try to find the source of an outbreak in the city's north. Credit: Sandra Sanders/Reuters Evidence of a SARS-CoV-2 strain was recently detected in Melbourne wastewater, leading to the detection of 15 locally acquired cases of COVID-19. Victorian Chief Health Officer Brett Sutton has confirmed that the strain is the B1.617 variant first detected in India. The strain was genetically linked to the man who contracted the virus wh...

4 min read The small archipelago nation of Seychelles, northeast of Madagascar in the Indian Ocean, has emerged as the world’s most vaccinated country for COVID-19. Around 71% of people have had at least one dose of a COVID vaccine, and 62% have been fully vaccinated. Of these, 57% have received the Sinopharm vaccine, and 43% AstraZeneca. Despite this, there has been a recent surge in cases, with 37% of new active cases and 20% of hospital cases being fully vaccinated. The country has had to reimpose some restrictions. How can this be happening? There are several possible ex...

Abstract Biosafety Level 4 labs are in the spotlight as speculation swirls that Covid-19 may have emerged from such a facility in either China or the US.  In the US, the mass proliferation of high-containment germ labs since 9/11, and its track record of safety lapses, remains a concern with the renewed interest in the field of biodefense.  In light of past accidents of anthrax leaks in US labs and SARS leak in Chinese labs, there needs to be improved regulation and governance of germ labs in order to mitigate rising risks of accidents that threaten public health, redress safety lapse provi...

The confusion, which comes as several governments commit to inoculating their citizens with Sinovac’s shot, is fueling skepticism over Chinese vaccines.

One Chinese vaccine and 4 efficacy rates confuse experts, raise doubts Premium A medical worker shows a syringe with the Sinovac Biotech vaccine against the COVID-19 coronavirus at a healthcare centre. (AFP) . Updated: 13 Jan 2021, 09:56 AM IST Bloomberg Uncertainty swirls over the efficacy of the leading Chinese shot, for which four different protection rate numbers have been released in recent weeks Overlapping efficacy data is not unprecedented in the Covid-19 vaccine race Share Via Read Full Story Days before a global rollout kicks off with the President of Indonesia receiving the Sino...